Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lior Zelcbuch

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
FEBS Letters|November 28, 2009
Direct proteasome binding and subsequent degradation of unspliced XBP-1 prevent its intracellular aggregationAmi Navon, Ariel Gatushkin, Lior Zelcbuch, et al.
ACS Synthetic Biology|May 10, 2013
Quantifying translational coupling in E. coli synthetic operons using RBS modulation and fluorescent reportersAyelet Levin-Karp, Uri Barenholz, Tasneem Bareia, et al.
Plos One|March 31, 2015
An in vivo metabolic approach for deciphering the product specificity of glycerate kinase proves that both E. coli's glycerate kinases generate 2-phosphoglycerateLior Zelcbuch, Manuel Razo-Mejia, Elad Herz, et al.
Biochemistry|April 20, 2016
Pyruvate Formate-Lyase Enables Efficient Growth of Escherichia coli on Acetate and FormateLior Zelcbuch, Steffen N Lindner, Yonatan Zegman, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Luminescent Phage-Based Detection of <i>Klebsiella pneumoniae</i>: From Engineering to DiagnosticsLior Zelcbuch, Elad Yitzhaki, Olga Nissan, et al.
Nucleic Acids Research|March 9, 2013
Spanning high-dimensional expression space using ribosome-binding site combinatoricsLior Zelcbuch, Niv Antonovsky, Arren Bar-Even, et al.
Cell|June 28, 2016
Sugar Synthesis from CO2 in Escherichia coliNiv Antonovsky, Shmuel Gleizer, Elad Noor, et al.
Nature Communications|July 2, 2025
Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Nature Communications|February 27, 2026
Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Cell|August 5, 2022
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammationSara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
FEBS Letters|November 28, 2009
Direct proteasome binding and subsequent degradation of unspliced XBP-1 prevent its intracellular aggregationAmi Navon, Ariel Gatushkin, Lior Zelcbuch, et al.
ACS Synthetic Biology|May 10, 2013
Quantifying translational coupling in E. coli synthetic operons using RBS modulation and fluorescent reportersAyelet Levin-Karp, Uri Barenholz, Tasneem Bareia, et al.
Plos One|March 31, 2015
An in vivo metabolic approach for deciphering the product specificity of glycerate kinase proves that both E. coli's glycerate kinases generate 2-phosphoglycerateLior Zelcbuch, Manuel Razo-Mejia, Elad Herz, et al.
Biochemistry|April 20, 2016
Pyruvate Formate-Lyase Enables Efficient Growth of Escherichia coli on Acetate and FormateLior Zelcbuch, Steffen N Lindner, Yonatan Zegman, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Luminescent Phage-Based Detection of <i>Klebsiella pneumoniae</i>: From Engineering to DiagnosticsLior Zelcbuch, Elad Yitzhaki, Olga Nissan, et al.
Nucleic Acids Research|March 9, 2013
Spanning high-dimensional expression space using ribosome-binding site combinatoricsLior Zelcbuch, Niv Antonovsky, Arren Bar-Even, et al.
Cell|June 28, 2016
Sugar Synthesis from CO2 in Escherichia coliNiv Antonovsky, Shmuel Gleizer, Elad Noor, et al.
Nature Communications|July 2, 2025
Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Nature Communications|February 27, 2026
Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Cell|August 5, 2022
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammationSara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas, et al.
Pageof 1